Bloc Operatoire Cardiaque | Delynov Cardiaque

Bloc Operatoire Cardiaque

Mitral and tricuspid repair: 92% long-term success at 2 years

Delynov Chirurgie, Delynov

Mitral and tricuspid repair: 92% long-term success at 2 years

The long-term durability of mitral valve repair for degenerative mitral regurgitation (DMR) remains the primary criterion for surgical success. Despite its significance, longitudinal data...

Feb 1, 2026

Degenerative mitral regurgitation: does repair remain the preferred option?

Delynov Chirurgie, Delynov

Degenerative mitral regurgitation: does repair remain the preferred option?

Degenerative mitral regurgitation (DMR) is the most common form of primary mitral regurgitation in developed countries, driven by an ageing population.

Feb 1, 2026

Post-infarction mitral papillary muscle rupture: surgery ensures a good prognosis

Delynov Chirurgie, Delynov

Post-infarction mitral papillary muscle rupture: surgery ensures a good prognosis

Severe mitral regurgitation (MR) following acute myocardial infarction is a rare but life-threatening mechanical complication associated with high mortality. This study analyses a...

Jan 29, 2026

Pediatric Mitral Valve Repair: Leaflet Augmentation Promotes Sustainable Growth

Delynov Chirurgie, Delynov

Pediatric Mitral Valve Repair: Leaflet Augmentation Promotes Sustainable Growth

Mitral valve surgery in children represents a challenging balance between immediate hemodynamic correction and the preservation of valvular growth potential. The augm...

Jan 28, 2026

Cardiac robotics: a learning curve secured by milestones

Delynov Chirurgie, Delynov

Cardiac robotics: a learning curve secured by milestones

Robotic cardiac surgery has established itself as a gold standard minimally invasive approach, promising reduced operative trauma and accelerated recovery. C...

Jan 21, 2026

Tricuspid annuloplasty: ring reduces recurrence compared to De Vega technique

Delynov Chirurgie, Delynov

Tricuspid annuloplasty: ring reduces recurrence compared to De Vega technique

Tricuspid regurgitation (TR) is no longer considered a simple benign secondary pathology. Its direct link to the progression of right ventricular failure and...

Jan 20, 2026

Endocarditis: the fulminant expansion of a pre-existing cerebral aneurysm

Delynov Chirurgie, Delynov

Endocarditis: the fulminant expansion of a pre-existing cerebral aneurysm

In the context of infective endocarditis (IE), the development of infectious intracranial aneurysms (IIA) is typically described as a de novo phenomenon resulting from embo...

Jan 15, 2026

Percutaneous tricuspid replacement: the major asset for massive regurgitation

Delynov Chirurgie, Delynov

Percutaneous tricuspid replacement: the major asset for massive regurgitation

Functional tricuspid regurgitation, long undertreated, exposes patients to a deleterious cascade: right heart failure, systemic congestion, and excess mortality.

Jan 12, 2026

Mitral valve repair: durable success in primary, higher risks in functional

Delynov Chirurgie, Delynov

Mitral valve repair: durable success in primary, higher risks in functional

Mitrale valve repair has become the gold standard treatment for mitral regurgitation (MR), though its actual impact on cardiac remodeling remains complex to a...

Jan 12, 2026

Minimally Invasive Mitral Surgery: Heart Team Reduces Stays and Complications

Delynov Chirurgie, Delynov

Minimally Invasive Mitral Surgery: Heart Team Reduces Stays and Complications

Minimally invasive mitral surgery (MIS) via right mini-thoracotomy has emerged as an effective alternative to median sternotomy, offering accelerated recovery and improved clinical outcomes.

Jan 9, 2026

M-TEER: a renal resistance index > 0.70 predicts mortality

Delynov Chirurgie, Delynov

M-TEER: a renal resistance index > 0.70 predicts mortality

In the management of severe mitral regurgitation (MR) in high-risk surgical patients, rigorous selection of candidates for Mitral Transcatheter Edge-to-Edge Repair (M-TEER) is essential. This article details the clinical and anatomical criteria required to optimize procedural success.

Jan 8, 2026

TEER and mitral regurgitation: an effective bridge to heart transplantation?

Delynov Chirurgie, Delynov

TEER and mitral regurgitation: an effective bridge to heart transplantation?

Advanced heart failure (HF), when complicated by significant secondary mitral regurgitation (MR), imposes a poor prognosis. While cardiac transplantation...

Jan 7, 2026

9
10
11
12
13